China Molybdenum H revenue and financials

3993 · HKEX · HKD

Secondary listing. The primary listing is CMOC Group · SSE (CNY)

$15.32Change from previous close: −0.65%Absolute change: −$0.10

Close · October 7, 2026

In the fiscal year ended December 2025, China Molybdenum H reported revenue of ¥206.44B (−3.01% year over year). Net income was ¥20.34B, a net margin of 9.9%.

Annual revenue · 2025: ¥206.44B
  1. ¥172.68B2022
  2. ¥185.98B2023
  3. ¥212.85B2024
  4. ¥206.44B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
−3.01%
2025 vs 2024
Net income growth
+50.30%
2025 vs 2024
Net margin
9.9%
2024: 6.4%

Financial data

Amounts in millions of CNY; per-share values in CNY; shares in millions.

Balance sheet · Annual
Item20252024202320222021
Total assets200,932170,236172,975165,019—
Current assets110,34879,17483,64885,682—
Cash and equivalents32,22328,03930,71632,648—
Short-term investments11,1506,5108,2854,237—
Inventory40,60129,87831,43032,255—
Net property, plant and equipment69,96571,16570,05961,241—
Goodwill427437430423—
Other intangible assets843652658861—
Long-term investments3,8983,2832,2291,934—
Current liabilities71,09745,46148,98050,061—
Accounts payable3,2863,2212,3351,018—
Long-term debt1,1669,33420,76821,125—
Total debt32,34730,24850,86552,850—
Total liabilities101,14684,294101,012102,982—
Total equity (incl. minority)99,78785,94271,96262,037—
Retained earnings48,92034,09323,97818,020—
Minority interest17,35114,91912,42210,339—